Ovarian cancer cell proliferation

Ovarian cancer cell proliferation refers to the pathological process of rapid and uncontrolled division of malignant cells within the ovarian tissue. This process is a core hallmark of cancer, facilitating tumor expansion, peritoneal seeding, and distant metastasis (Hanahan & Weinberg, 2011). It is typically driven by genetic mutations—such as those in TP53 or BRCA1/2—and the dysregulation of growth-signaling pathways like PI3K/AKT/mTOR and MAPK/ERK (Bast et al., 2009). While many therapeutic agents, including platinum-based chemotherapies and PARP inhibitors, are used to suppress this growth, "Ovarian cancer cell proliferation" is a biological outcome or phenotype rather than a discrete molecular target like a receptor or enzyme. Effective management of this proliferation requires targeting the specific molecular drivers unique to the tumor's profile (Matulonis et al., 2016).

Other names

Ovarian tumor cell growthOvarian carcinoma cell proliferationProliferation of ovarian cancer cells

Not applicable; this is a biological process/phenotype rather than a molecular target.